Accelerating Trial Timelines: SCOPE Summit 2026
At #SCOPE2026 in Orlando FL, our CEO Alive Xiao had the privilege of joining a strategic dialogue within the "AI in Clinical Research" program. Alongside visionaries from Pfizer, AbbVie, and Otsuka, and many other industry leaders.
We tackled a critical question: How do we move from simple digitization to true Agentic Intelligence?
Three major shifts are redefining our industry:
1) From Digits to Agency: We’re moving beyond "tools" to Multi-Agent Systems that manage clinical trial data integrity and compliance from Day 1.
2) The End of Manual Heavy-Lifting: At Angelonia AI, protocol amendments, informed consent form (ICFs) and Case Report Forms (CRFs) don't have to be bottlenecks. We are automating the drafting process so teams can focus on science, not formatting.
3) Speed of Thought: When documentation isn't a barrier, life-saving therapies reach patients faster.
It’s a privilege to build alongside the visionaries redefining Clinical Operations for an AI-native era.
If you are interested in discussing how your teams can save 30% of their time on documentation writing or want to learn more about Angelonia, you can book time directly with Alive Xiao here: https://calendly.com/alivexiao-angelonia
